Moxonidin Abz (Moxonidine)

Moxonidine acts as a selective agonist at central imidazoline I1 receptors. Stimulation of these receptors diminishes sympathetic nervous system activity, which leads to reduced peripheral vascular resistance and lower arterial blood pressure.

The appropriate dose of Moxonidin Abz is determined by a qualified prescriber based on the individual’s blood‑pressure profile, response to therapy, and any co‑existing medical conditions. Patients should follow the dosing instructions provided by their healthcare professional.

Safety data for moxonidine in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a healthcare provider after careful evaluation.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Moxonidine belongs to the class of central‑acting imidazoline receptor agonists, offering a distinct mechanism from ACE inhibitors, ARBs, calcium‑channel blockers, or diuretics. It is particularly useful when sympathetic over‑activity contributes to hypertension or when additional blood‑pressure control is needed alongside other agents.

Store Moxonidin Abz at temperatures below 25 °C, in the original packaging, and protect it from moisture and direct sunlight. Keep the product out of reach of children and do not use it after the expiry date printed on the label.

Moxonidin Abz is taken orally, usually once daily, with or without food as directed by the prescribing clinician. Swallow the tablet whole with a glass of water; do not crush or chew unless specifically instructed.

Serious adverse events, although uncommon, include severe hypotension, marked bradycardia, and allergic skin reactions such as rash or angioedema. Patients should seek immediate medical attention if they experience fainting, rapid heartbeat, or signs of an allergic response.

Moxonidin Abz is contraindicated in individuals with known hypersensitivity to moxonidine or any excipients in the formulation. Caution is advised for patients with severe hepatic impairment, uncontrolled heart failure, or those taking other central antihypertensive agents without medical supervision.